Royalty Statements. Celldex shall deliver to Medarex within forty-five (45) days after the end of each Calendar Quarter in which Royalty-Bearing Products, for which Celldex owes a royalty hereunder, are sold, a detailed statement showing (a) Net Sales of each such Royalty-Bearing Product on a country-by-country basis during the applicable Calendar Quarter, and (b) the amount and calculation of royalties due on such Net Sales.
Appears in 4 contracts
Samples: Assignment and License Agreement (Celldex Therapeutics Inc), Assignment and License Agreement (Celldex Therapeutics Inc), Assignment and License Agreement (Avant Immunotherapeutics Inc)
